Clinical Studies and Therapies in Parkinson's Disease

Translations from Preclinical Models

Juan Segura-Aguilar
Elsevier S&T
306 pages
ISBN: ‎ 978-0128221204
June 2021

Numerous preclinical investigations based on endogenous neurotoxin models have promised various therapies for Parkinson’s disease, but these efforts have failed when attempting to transfer these successful results to preclinical studies. This book analyzes why they have failed. Neuroscientists, neurologists, and neuropharmacologists will benefit greatly from the book’s discussion of newer models, their benefits, and the need for their implementation. This book also provides the basic concepts of dopamine metabolism for students taking courses in neurochemistry, neuroscience, neuropharmacology, biochemistry, and medicine.